The place of antenatal corticosteroids in late preterm and early term births.

Antenatal steroids Caesarean section Intrauterine growth restriction Maternal diabetes Pregnancy Respiratory complications Twins

Journal

Seminars in fetal & neonatal medicine
ISSN: 1878-0946
Titre abrégé: Semin Fetal Neonatal Med
Pays: Netherlands
ID NLM: 101240003

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 17 10 2018
medline: 16 4 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

Infants born in the late preterm period and via non-labour caesarean section in the early term period are at increased risk of respiratory morbidity when compared to their term-born counterparts. The morbidity in these infants is less frequent and severe than in early preterm infants. Antenatal corticosteroids reduce respiratory morbidity in these populations; however, the magnitude of the reduction appears to be small and predominantly in the self-limiting condition of transient tachypnoea of the neonate. The smaller benefit, along with possible harmful effects of corticosteroids, raises a question about the role of antenatal corticosteroids in this population. Special obstetric populations such as twin pregnancies and pregnancies complicated by diabetes and growth restriction are at increased risk of prematurity and more vulnerable to its complications. Nevertheless, there is limited evidence regarding the benefits of corticosteroids in these populations and potential concern regarding adverse effects. We recommend an individualised approach when administering corticosteroids at later gestations. In these specific obstetric populations, we do not currently recommend administering corticosteroids in the late preterm/early term periods until more evidence is available.

Identifiants

pubmed: 30322825
pii: S1744-165X(18)30112-4
doi: 10.1016/j.siny.2018.10.001
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-42

Informations de copyright

© 2018 Published by Elsevier Ltd.

Auteurs

Hagar Rahel Haviv (HR)

Department of Obstetrics and Gynaecology, Women's and Children's Hospital, Adelaide, Australia. Electronic address: hagar.haviv@sa.gov.au.

Joanne Said (J)

Maternal Fetal Medicine, Sunshine Hospital, Western Health, Saint Albans, VIC, Australia; Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, VIC, Australia.

Ben Willem Mol (BW)

Department of Obstetrics and Gynaecology, Women's and Children's Hospital, Adelaide, Australia; Robinson Research Institute, Adelaide Medical School, North Adelaide, SA, Australia; Department of Obstetrics and Gynaecology, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH